ThesisEpidermal growth factor (EGF) gene polymorphism as a risk factor for development of hepatocellular carcinoma (HCC) in chronic liver disease patients
ThesisEpidermal growth factor (EGF) gene polymorphism as a risk factor for development of hepatocellular carcinoma (HCC) in chronic liver disease patients
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisThe role of glutathione -S- transferase gene mutation in the development of hepatocellular carcinoma
ThesisThe role of glutathione -S- transferase gene mutation in the development of hepatocellular carcinoma
ThesisClinical significance of detection of cyclooxygenase-2 (COX-2) in liver cells in patients with chronic liver disease and hepatocellular carcinoma
ThesisClinical significance of detection of cyclooxygenase-2 (COX-2) in liver cells in patients with chronic liver disease and hepatocellular carcinoma